Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

Selected Publications

Lung Injury & Repair Group

  1. Downing JF, Pasula R, Wright JR, Twigg III HL, Martin II WJ. Surfactant protein a promotes attachment of Mycobacterium tuberculossis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA 92:4848-52, 1995. [Abstract] Exit NIEHS
  2. Mathur PN, Hartman D, Martin II WJ. Thoracoscopy. In: Bone RC, Dantzker DR, George RB, Matthay RA, Reynolds HY, eds. Pulmonary and Critical Care Medicine. St. Louis, MO: Mosby-Year Book, Inc.; 1995:1-8.
  3. McMahon JP, Wheat L, Sobel ME, Pasula R, Downing JF, Martin II WJ. Murine laminin binds to Histoplasma capsulatum: a possible mechanism of dissemination. J Clin Invest 96:1010-7, 1995. [Abstract] Exit NIEHS
  4. Rose RM, Martin II WJ. Adhesion molecules and respiratory pathogens. In: Ward PA, ed. Adhesion Molecules and the Lung. New York: Marcel Dekker Inc.; 1995:147-58.
  5. Martin II WJ, Downing JF, Williams MD, Pasula R, Twigg III HL, Wright JR. Role of surfactant protein A in the pathogenesis of tuberculosis in subjects with human immunodeficiency virus infection. Proc Assoc Am Phys 107(3):340-5, 1995. [Abstract] Exit NIEHS
  6. Williams MD, Wright JR, March KL, Downing J, Martin II WJ. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol 14(3):232-8, 1996. [Abstract] Exit NIEHS
  7. Su TH, Natarajan V, Kachel DL, Moxley MA, Longmore WJ, Martin II WJ. Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med 127(3):263-71, 1996. [Abstract] Exit NIEHS
  8. Martin II WJ. A health policy approach to cigarette smoking and tobacco related diseases. J Clin Out Management 3:44-5, 1996.
  9. Weaver T, Hall CL, Kachel DL, Ward RP, Williams MD, Perry DG, Wisniowski P, Martin II WJ. Assessment of in vivo attachment/phagocytosis by alveolar macrophages. J Immunol Methods 193:149-56, 1996. [Abstract] Exit NIEHS
  10. Martin II W. Principles of Good Grant Writing. In: Martin II W, ed. Grant Writing  Successful techniques for securing pulmonary research funding: Kendall/Hunt Publishing; 1996:35-42.
  11. Martin II W. Grant Writing.  Successful techniques for securing pulmonary research funding: Kendall/Hunt Publishing; 1996.
  12. Martin II WJ. Injury from Drugs. In: Crystal RG, West J, eds. The Lung: Scientific Foundations. 2nd edition ed: Raven Press; 1997:2465-73.
  13. Heffner J, Sznajder JI, Martin WJ. The HCFA proposal for changes in Medicare practice expenses: need for legislative action. Am J Respir Crit Care Med 155(6):i-ii, 1997. [Abstract] Exit NIEHS
  14. Pasula R, Downing JF, Wright JR, Kachel DL, Davis Jr. TE, Martin II WJ. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol 17:209-17, 1997. [Abstract] Exit NIEHS
  15. Perry D, Wisniowski P, Downing J, Martin II WJ. Nonimmune phagocytosis of liposomes by rat alveolar macrophages is enhanced by vitronectin and is vitronectin-receptor-mediated. Am J Respir Cell Mol Biol 17:462-70, 1997. [Abstract] Exit NIEHS
  16. Schwartz D, Torres K, Addison T, Bailey T, C, Kelling Jr D, Make B, Martin II W, McBride J, Meeks Jr C, Nathinson I, Rearden H, Richards D, Rose C, Strawbridge R, Terry P. A framework for health care policy in the United States. Am J Respir Crit Care Med 156:1011-5, 1997. [Abstract] Exit NIEHS
  17. Martin II W. Health and Science Legislation in the United States. In: Matalon S, Sznajder JI, eds. Acute Respiratory Distress Syndrome: Cellular and Molecular Mechanisms and Clinical Management. New York: Plenum Press; 1998:415-20.
  18. Martin II W. Pneumocystis carinii: the art and science of survival in the hostile environment of the alveolar spaces. Semin Respir Infect 13(4):348-52, 1998. [Abstract] Exit NIEHS
  19. Zhu S, Kachel D, Martin II WJ, Matalon S. Nitrated SP-A does not enhance adherence of  Pneumocystis carinii to alveolar macrophages. Am J Physiol 275(19):L1031-L9, 1998. [Abstract] Exit NIEHS
  20. Twigg III HL, Martin II W. Immunologic and non-immunologic lung defense mechanisms. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yuninger JW, eds. Allergy Principles and Practice. 5th ed. St. Louis, MO: CV Mosby Co.; 1998:477-94.
  21. Perry DG, Daugherty G, Martin II WJ. Clathrin-coated pit-associated proteins are required for alveolar macrophage phagocytosis. J Immunol 162:380-6, 1999. [Abstract] Exit NIEHS
  22. Downing JF, Kachel DL, Pasula R, Martin II WJ. Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun 67:1347-52, 1999. [Abstract] Exit NIEHS
  23. Pasula R, Wright J, Martin II WJ. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 103:483-90, 1999. [Abstract] Exit NIEHS
  24. Martin II W, Wright J. Pneumocystis carinii pneumonia and pulmonary surfactant. J Lab Clin Med 133:406-7, 1999. [Abstract] Exit NIEHS
  25. Spech RW, Wisniowski P, Kachel DL, Wright JR, Martin II W. Surfactant protein A prevents silica-mediated toxicity to rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 278(4):L713-8, 2000. [Abstract] Exit NIEHS
  26. Mishra A, Doyle NA, Martin II W. Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. Am J Respir Cell Mol Biol 22(5):543-9, 2000. [Abstract] Exit NIEHS
  27. Behnia M, Robertson KA, Martin II W. Lung infections: role of apoptosis in host defense and pathogenesis of disease. Chest 117(6):1771-7, 2000. [Abstract] Exit NIEHS
  28. Wisniowski PE, Spech RW, Wu M, Doyle NA, Pasula R, Martin II WJ. Vitronectin protects alveolar macrophages from silica toxicity. Am J Respir Crit Care Med 162(2 Pt 1):733-9, 2000. [Abstract] Exit NIEHS
  29. Martin II W, Pasula R. Role of alveolar macrophages in host defense against Pneumocystis carinii. Am J Respir Cell Mol Biol 23(4):434-5, 2000. [Abstract] Exit NIEHS
  30. Wu M, Kelley MR, Hansen WK, Martin II W. Reduction of BCNU toxicity to lung epithelial cells by high level expression of O6 methylguanine-DNA methyltransferase. American Journal of Physiology Lung Cell Molecular Physiology 280(4):L755-L61, 2000.
  31. He Y-H, Kelley M, Wu M, Williams DA, Martin II WJ. Expression of yeast apurinic/apurimidinic endonuclease (APN1) protects lung endothelial cells against bleomycin toxicity. Am J Respir Cell Mol Biol 25:692-8, 2001. [Abstract] Exit NIEHS
  32. American Lung Association Asthma Clinical Research Centers [WJ Martin II PI, ACRC, Indiana University. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 345(21):1529-36, 2001. [Abstract] Exit NIEHS
  33. Wu M, Hussain S, He Y-H, Pasula R, Smith P, Martin II W. Genetically engineered macrophages expressing IFN-g restore alveolar immune function in scid mice. Proc Natl Acad Sci USA 98:14589-94, 2001. [Abstract] Exit NIEHS
  34. He Y-H, Xu Y, Kobune M, Wu M, Kelley MR, Martin II WJ. Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells. Am J Physiol Lung Cell Mol Physiol 282:L50-L5, 2002. [Abstract] Exit NIEHS
  35. Pasula R, Wisniowski P, Martin II W. Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages. Infect Immun 70(3):1287-92, 2002. [Abstract] Exit NIEHS
  36. Wu M, Stockley PG, Martin II WJ. An improved Western blotting technique effectively reduces background. Electrophoresis 23:2373-6, 2002. [Abstract] Exit NIEHS
  37. Pasula R, Weaver T, Martinez M, Martin II WJ. Morphologic detection and functional assessment of reconstituted normal alveolar macrophages in the lungs of scid mice. J Immunol 169:4504-10, 2002. [Abstract] Exit NIEHS
  38. Wu M, He Y-H, Xu Y, Kobune M, Kelley MR, Williams DA, Martin II WJ. Protection of human lung cells against hyperoxia using the DNA base excision repair genes hOgg1 and Fpg. Am J Respir Crit Care Med 166:192-9, 2002. [Abstract] Exit NIEHS
  39. Hussain S, Wright JR, Martin II W. Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factor-a-dependent mechanism. Am J Respir Cell Mol Biol 28:520-7, 2003. [Abstract] Exit NIEHS
  40. Boulware D, Forger W, Martin II WJ. Medical risks of wilderness hiking. Am J Med 114(4):288-93, 2003. [Abstract] Exit NIEHS
  41. Wu M, Pasula R, Smith P, Martin II WJ. Mapping alveolar binding sites in vivo using phage peptide libraries. Gene Ther 10:1429-36, 2003. [Abstract] Exit NIEHS
  42. Zhang D, Wu M, Nelson D, Pasula R, Martin II WJ. Alpha-1-antitrypsin expression in lung is increased by airway delivery of gene-transfected macrophages. Gene Ther 10:2148-52, 2003. [Abstract] Exit NIEHS
  43. Day R, Wang Y, Knox K, Pasula R, Martin II WJ, Twigg III HL. Alveolar macrophages from HIV infected subjects are resistant to Mycobacterium tuberculosis in vitro. Am J Respir Cell Mol Biol 30:403-10, 2004. [Abstract] Exit NIEHS
  44. Martin II WJ, Iannuzzi MC, Gail DB, Peavy HH. Future directions in sarcoidosis research: summary of an NHLBI working group. Am J Respir Crit Care Med 170:567-71, 2004. [Abstract] Exit NIEHS
  45. Camus P, Martin II WJ, Rosenow E. Amiodarone Pulmonary Toxicity. Clin Chest Med 1:65-75, 2004. [Abstract] Exit NIEHS
  46. Martin II WJ, Wu M, Pasula R. A novel approach to restore lung immunity during systemic immunosuppression. Trans Am Clin Climatol Assoc 116:221-7, 2005. [Abstract] Exit NIEHS
  47. Schwartz DA, Martin, WJ.  Translating Translational Biomedicine for Environmental Health.  Environ Health Perspect 114: A206, 2006. [Abstract] Exit NIEHS
  48. Mullen M, Wetzel CC, Parks J, Mark L, Martin II WJ.  New Simplified Approach for Cell-Based Therapy to the Lung.  (In revision), 2006.
  49. Schwartz DA. Martin, WJ NIEHS Director’s perspective.  HEALing in New Orleans.  Environ Health Perspect 114: A570, 2006.
  50. Pasula R, Martin II WJ.  Reconstitution of activated alveolar macrophages into the lungs of SCID mice reduces Pneumocystis carinii infection.  (Submitted)  2006.
  51. Martin II WJ, Mullen M, Wetzel CC, Morris R.  Airway delivery of donor type II alveolar epithelial cells in bleomycin-injured mice.  (Submitted)  2006.
  52. Rom WN, Pinkerton KE, Martin WJ, Forastiere F. Global warming: a challenge to all American Thoracic Society members. American journal of respiratory and critical care medicine 177(10):1053-1054, 2008. [Abstract] ( Exit NIEHS

Back to top Back to top Department of Health & Human Services National Institutes of Health
This page URL:
NIEHS website:
Email the Web Manager at
Last Reviewed: July 09, 2008